We have introduced the fundus retinopathy screening system which recognited by CE in Europe and FDA in America, patented equipment of Chengdu Ineye Hospital, China, that can screen the fundus angiography, analyze by AI artificial intelligence, and generate the report. With our high accuracy, fast processing, and convenient eye scanning system, the occurrence and change of physical diseases, such as diabetic retinopathy, hypertension, and other chronic vascular diseases can be detected earlier, prevention and treatment can be carried out.
As we know, changes in microvascular and microcirculation, can be reflected in the microvascular of the retina. And we can directly observed it with non-invasive method. Checking the state of retinal microvascular is of great significance to the early prediction and diagnosis of major diseases.
